Arvinas, Inc.
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera…
Biotechnology
US, New Haven [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Arvinas, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDArvinas, Inc. can't present revenue by segment